Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication
The FDA approved label expansions for bempedoic acid (Nexletol) and bempedoic acid/ezetimibe (Nexlizet) so they can be used more broadly as cardiovascular prevention drugs, Esperion announced Friday. Based on the CLEAR Outcomes trial, the two adenosine triphosphate (ATP) citrate lyase inhibitor drugs are now indicated for adults with either established atherosclerotic cardiovascular disease (CVD) or […]
HHS Secretary Supports Telehealth Expansion, Emphasizes Need for Equity
Should telehealth expansions be made permanent after the COVID-19 pandemic? And if they do become law, how can equity be ensured? HHS Secretary Xavier Becerra and Jack Resneck Jr., MD, president-elect of the American Medical Association (AMA), weighed in on these and other questions during an interview with the Washington Post on Thursday. Over 43 […]